0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug/Vaccine Safety
 1-20 of 572 Articles
JAMA Oncology | 
Original Investigation |  ONLINE FIRST
Jonathan Douxfils, PharmD, PhD; Hélène Haguet, MBS; François Mullier, PharmD, PhD; et al.
JAMA Oncol. Published online February 04, 2016. doi:10.1001/jamaoncol.2015.5932
Includes: Supplemental Content

JAMA Oncology | 
Review |  ONLINE FIRST
Gary W. Jean, PharmD; Rene M. Mani, PharmD; Aliza Jaffry, PharmD; et al.
JAMA Oncol. Published online February 04, 2016. doi:10.1001/jamaoncol.2015.5927

JAMA | 
From The Medical Letter on Drugs and Therapeutics | 
JAMA. 2016;315(5):510-511. doi:10.1001/jama.2016.0048.

JAMA Internal Medicine | 
Viewpoint |  ONLINE FIRST
Amy Kapczynski, JD
JAMA Intern Med. Published online February 01, 2016. doi:10.1001/jamainternmed.2015.8155

JAMA Internal Medicine | 
Original Investigation | 
Benjamin Lazarus, MBBS; Yuan Chen, MS; Francis P. Wilson, MD, MS; et al.
JAMA Intern Med. 2016;176(2):238-246. doi:10.1001/jamainternmed.2015.7193.

JAMA Internal Medicine | 
Editorial | 
Steven R. Cummings, MD; Douglas P. Kiel, MD, MPH; Dennis M. Black, PhD
JAMA Intern Med. 2016;176(2):171-172. doi:10.1001/jamainternmed.2015.7568.

JAMA Internal Medicine | 
Original Investigation | 
Heike A. Bischoff-Ferrari, MD, DrPH; Bess Dawson-Hughes, MD; E. John Orav, PhD; et al.
JAMA Intern Med. 2016;176(2):. doi:10.1001/jamainternmed.2015.7148.
Includes: Supplemental Content

JAMA Internal Medicine | 
Perspective | 
Fiona Clement, PhD
JAMA Intern Med. 2016;176(2):163-164. doi:10.1001/jamainternmed.2015.7186.

JAMA Internal Medicine | 
Original Investigation | 
Ajay Dharod, MD; Elsayed Z. Soliman, MD, MSc, MS; Farah Dawood, MD; et al.
JAMA Intern Med. 2016;176(2):219-227. doi:10.1001/jamainternmed.2015.7655.
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation | 
Shelli R. Kesler, PhD; Douglas W. Blayney, MD
JAMA Oncol. 2016;2(2):185-192. doi:10.1001/jamaoncol.2015.4333.
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation | 
Douglas B. Johnson, MD; Ryan J. Sullivan, MD; Patrick A. Ott, MD, PhD; et al.
JAMA Oncol. 2016;2(2):234-240. doi:10.1001/jamaoncol.2015.4368.
Includes: Supplemental Content

JAMA Neurology | 
Original Investigation | 
Jan C. Purrucker, MD; Kirsten Haas, MPH, PhD; Timolaos Rizos, MD; et al.
JAMA Neurol. 2016;73(2):169-177. doi:10.1001/jamaneurol.2015.3682.
Includes: Supplemental Content

JAMA Pediatrics | 
Editorial | 
Bryan H. King, MD, MBA
JAMA Pediatr. 2016;170(2):111-112. doi:10.1001/jamapediatrics.2015.3493.

JAMA Pediatrics | 
Original Investigation | 
Takoua Boukhris, MSc; Odile Sheehy, MSc; Laurent Mottron, MD, PhD; et al.
JAMA Pediatr. 2016;170(2):117-124. doi:10.1001/jamapediatrics.2015.3356.
Includes: CME, Supplemental Content

JAMA Dermatology | 
Original Investigation | 
Frank I. Scott, MD, MSCE; Ronac Mamtani, MD, MSCE; Colleen M. Brensinger, MS; et al.
JAMA Dermatol. 2016;152(2):164-172. doi:10.1001/jamadermatol.2015.3029.
Includes: Supplemental Content

JAMA Oncology | 
JAMA Oncology Diagnostic Test Interpretation | 
Nibal Rizk, MD; Carlos Kamiya-Matsuoka, MD; Ivo W. Tremont-Lukats, MD
JAMA Oncol. 2016;2(2):265-266. doi:10.1001/jamaoncol.2015.4301.

JAMA Oncology | 
Editorial | 
Kelly N. H. Nudelman, PhD; Brenna C. McDonald, PsyD; Andrew J. Saykin, PsyD
JAMA Oncol. 2016;2(2):174-176. doi:10.1001/jamaoncol.2015.4551.

JAMA Oncology | 
Editor's Note |  FREE
Mary L. Disis, MD
JAMA Oncol. 2016;2(2):241. doi:10.1001/jamaoncol.2015.4717.

JAMA Internal Medicine | 
Research Letter |  ONLINE FIRST
Christopher M. Jones, PharmD, MPH; Peter G. Lurie, MD, MPH; Douglas C. Throckmorton, MD
JAMA Intern Med. Published online January 25, 2016. doi:10.1001/jamainternmed.2015.7799

JAMA Oncology | 
Invited Commentary |  ONLINE FIRST
Steven M. Offer, PhD; Robert B. Diasio, MD
JAMA Oncol. Published online January 21, 2016. doi:10.1001/jamaoncol.2015.5463

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Original Investigation  | 
Association Between BCR-ABL Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia and Cardiovascular Events, Major Molecular Response, and Overall Survival A Systematic Review and Meta-analysis
Jonathan Douxfils, PharmD, PhD; Hélène Haguet, MBS; François Mullier, PharmD, PhD; et al.
JAMA Oncology
Review  | 
Toxic Effects of Sorafenib in Patients With Differentiated Thyroid Carcinoma Compared With Other Cancers
Gary W. Jean, PharmD; Rene M. Mani, PharmD; Aliza Jaffry, PharmD; et al.
JAMA
From The Medical Letter on Drugs and Therapeutics  | 
Drugs Past Their Expiration Date

JAMA Dermatology
Original Investigation  | 
Risk of Nonmelanoma Skin Cancer Associated With the Use of Immunosuppressant and Biologic Agents in Patients With a History of Autoimmune Disease and Nonmelanoma Skin Cancer
Frank I. Scott, MD, MSCE; Ronac Mamtani, MD, MSCE; Colleen M. Brensinger, MS; et al.